What is it about?
18F-FDG PET/CT is an effective predictor of therapeutic responses and outcomes in DLBCL. However its prognostic value is debated due to heterogeneous interpretation scales. This paper was intended to investigate whether the SUVmax-liver-based interpretation could be better method.
Featured Image
Why is it important?
Our findings show that SUVmax-liver-based criteria, using the liver uptake as a reference to evaluate PET/CT, was superior to Deauville 5-PS and %DSUVmax criteria. This interpretation can improve prognostic accuracy of interim and posttreatment PET.
Perspectives
Writing this article was a great pleasure as it shows value in daily practical clinical application. Our work investigated a better interpretation of PET and we can use this method to interpret interim and end-of-treatment PET more precisely.
Yuewei Zhang
Peking University Cancer Hospital
Read the Original
This page is a summary of: Can the SUVmax-liver-based interpretation improve prognostic accuracy of interim and posttreatment 18F-FDG PET/CT in patients with diffuse large B-cell lymphoma?, Leukemia & Lymphoma, August 2017, Taylor & Francis,
DOI: 10.1080/10428194.2017.1357171.
You can read the full text:
Contributors
The following have contributed to this page
